Gender minority (GM) (people whose gender does not align with the sex assigned at birth) people have historically been insured at lower rates than the general population. The purpose of this review is to (1) assess the prevalence of health insurance among GM adults in the United States, (2) examine prevalence by gender, and (3) examine trends in prevalence before and after implementation of the Affordable Care Act.
Methods:
Published articles from PubMed, EMBASE, and Web of Science databases before April 26th, 2019, were included. This review is registered on PROSPERO (CRD42019133627). Analysis was guided by a random-effects model to obtain a meta-prevalence estimate for all GM people and stratified by gender subgroup. Heterogeneity was assessed using a Q-test and I2 measure.
Results:
Of 55 included articles, a random pooled estimate showed that 75% GM people were insured (95% confidence interval [CI]: 0.71–0.79; p<0.001). Subgroup analysis by gender determined 70% of transgender women (95% CI: 0.64–0.76; p<0.001; I2=97.16%) and 80% of transgender men (95% CI: 0.77–0.83; p=0.01; I2=54.51%) were insured. Too few studies provided health insurance prevalence data for gender-expansive participants (GM people who do not identify as solely man or woman) to conduct analysis.
Conclusion:
The pooled prevalence of health insurance among GM people found in this review is considerably lower than the general population. Standardized collection of gender across research and health care will improve identification of vulnerable individuals who experience this barrier to preventative and acute care services.
Get full access to this article
View all access options for this article.
References
1.
ShiL, SinghDA. Delivering Health Care in America. Burlington, MA, USA: Jones & Bartlett Learning, 2014.
2.
SmedleyBD, StithAY, NelsonAR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. USA: National Academies Press, 2003.
3.
BeerchickE, BarnettJ, UptonR. Health Insurance Coverage in the United States: 2018. 2019. Available at https://www.census.gov/content/dam/Census/library/publications/2019/demo/p60-267.pdf Accessed April28, 2020.
4.
ReisnerSL, ConronKJ, ScoutNfn, et al.“Counting” Transgender and Gender-Nonconforming Adults in Health Research: recommendations from the Gender Identity in US Surveillance Group. TSQ. 2015; 2:34–57.
5.
Institute of Medicine (US) Committee onLesbian, GayBisexual, and Transgender Health Issues and Research Gaps andOpportunities. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington D.C., USA: The National Academies Press, 2011.
6.
ColemanE, BocktingW, BotzerM, et al.Standards of care for the health of transsexual, transgender, and gender non-conforming people 7th version. Int J Transgend. 2012; 13:165–232.
7.
JamesSE, HermanJL, RankinS, et al. Executive summary of the report of the 2015U.S. transgender survey. 2015, Washington, DC: National Center for Transgender Equality.
8.
HughtoJMW, ReisnerSL. A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals. Transgend Health. 2016; 1:21–32.
9.
ClarkK, FletcherJB, HollowayIW, RebackCJ. Structural inequities and social networks impact hormone use and misuse among transgender women in Los Angeles County. Arch Sex Behav. 2018; 47:953–962.
10.
AsschemanH, T'SjoenG, LemaireA, et al.Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia. 2014; 46:791–795.
11.
MooreE, WisniewskiA, DobsA. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab. 2003; 88:3467–3473.
12.
RebackCJ, FletcherJB. HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS Behav. 2014; 18:1359–1367.
13.
McWilliamsJM.Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009; 87:443–494.
14.
BrookRH, KeelerEB, LohrKN, et al.The Health Insurance Experiment: A Classic RAND Study Speaks to the Current Health Care Reform Debate. Santa Monica, CA: RAND Corporation, 2006.
15.
FreemanJD, KadiyalaS, BellJF, MartinDP. The causal effect of health insurance on utilization and outcomes in adults: a systematic review of US studies. Med Care. 2008; 46:1023–1032.
16.
MaimarisW, PatyJ, PerelP, et al.The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013; 10:e1001490.
17.
HadleyJ.Sicker and poorer—the consequences of being uninsured: a review of the research on the relationship between health insurance, medical care use, health, work, and income. Med Care Res Rev. 2003; 60(2Suppl):3S–75S.
18.
RangelC.Patient Protection and Affordable Care Act. House of Representatives 3590, 111th Cong. (2010). Available at https://www.congress.gov/bill/111th-congress/house-bill/3590 Accessed March9, 2020.
19.
PRISMA. Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Published 2009. Available at www.prisma-statement.org/ Accessed November9, 2019.
20.
ClarkK, ShermanA, FlentjeA. Health insurance prevalence among gender minority people: A systematic review and meta-analysis. PROSPERO 2019 CRD42019133627 Available at https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019133627 Accessed June4, 2019.
21.
Covidence systematic review software, Veritas HealthInnovation, MelbourneAustralia. Available at www.covidence.org Accessed June4, 2019.
22.
NationalHeart, Lung, and BloodInstitute. Study Quality Assessment Tools. Available at https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Accessed April7, 2020.
23.
StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.
24.
PalmerTM, SterneJAC. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. College Station, TX: Stata Press, 2016.
25.
Kaiser Family Foundation. Status of State Action on the Medicaid Expansion Decision. Published 2019. Available at https://www.kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ Accessed April21, 2020.
26.
HillBJ, CrosbyR, BourisA, et al.Exploring transgender legal name change as a potential structural intervention for mitigating social determinants of health among transgender women of color. Sex Res Soc Policy. 2018; 15:25–33.
27.
JaffeeKD, ShiresDA, StroumsaD. Discrimination and delayed health care among transgender women and men implications for improving medical education and health care delivery. Med Care. 2016; 54:1010–1016.
28.
LightA, WangL-F, ZeymoA, Gomez-LoboV. Family planning and contraception use in transgender men. Contraception. 2018; 98:266–269.
29.
RaelCT, MartinezM, GiguereR, et al.Barriers and facilitators to oral PrEP use among transgender women in New York City. AIDS Behav. 2018; 22:3627–3636.
30.
SamuelsEA, TapeC, GarberN, et al.“Sometimes you feel like the freak show”: a qualitative assessment of emergency care experiences among transgender and gender-nonconforming patients. Ann Emerg Med. 2018; 71:170–182.e1.
31.
SeelmanKL, YoungSR, TeseneM, et al.A comparison of health disparities among transgender adults in Colorado (USA) by race and income. Int J Transgend. 2017; 18:199–214.
32.
ArayasirikulS, WilsonEC, RaymondHF. Examining the effects of transphobic discrimination and race on HIV risk among transwomen in San Francisco. AIDS Behav. 2017; 21:2628–2633.
33.
BazarganM, GalvanF. Perceived discrimination and depression among low-income Latina male-to-female transgender women. BMC Public Health. 2012; 12:663.
34.
BocktingWO, RobinsonBE, ForbergJ, ScheltemaK. Evaluation of a sexual health approach to reducing HIV/STD risk in the transgender community. AIDS Care. 2005; 17:289–303.
35.
BradfordJ, ReisnerSL, HonnoldJA, XavierJ. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013; 103:1820–1829.
36.
BraunHM, CandelarioJ, HanlonCL, et al.Transgender women living with HIV frequently take antiretroviral therapy and/or feminizing hormone therapy differently than prescribed due to drug–drug interaction concerns. LGBT Health. 2017; 4:371–375.
37.
BukowskiLA, ChandlerCJ, CreasySL, et al.Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr. 2018; 79:413.
38.
Clements-NolleK, MarxR, GuzmanR, KatzM. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health. 2001; 91:915.
39.
ConronKJ, ScottG, StowellGS, LandersSJ. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health. 2012; 102:118–122.
40.
DensonDJ, PadgettPM, PittsN, et al.Health care use and HIV-related behaviors of black and Latina transgender women in 3 US metropolitan areas: results from the transgender HIV behavioral survey. J Acquir Immune Defic Syndr. 2017; 75(Suppl 3):S268.
41.
DowningJM, PrzedworskiJM. Health of transgender adults in the US, 2014–2016. Am J Prev Med. 2018; 55:336–344.
42.
FeinLA, CunhaIR, SlomovitzB, PotterJ. Risk factors for anal dysplasia in transgender women: a retrospective chart review. J Low Genit Tract Dis. 2018; 22:336–339.
43.
FernandezJD, TannockLR. Metabolic effects of hormone therapy in transgender patients. Endocr Pract. 2016; 22:383–388.
44.
HarawaNT, BinghamTA. Exploring HIV prevention utilization among female sex workers and male-to-female transgenders. AIDS Educ Prev. 2009; 21:356–371.
45.
HarbCYW, PassLE, De SorianoIC, et al.Motivators and barriers to accessing sexual health care services for transgender/genderqueer individuals assigned female sex at birth. Transgend Health. 2019; 4:58–67.
46.
JenningsL, BarcelosC, McWilliamsC, MaleckiK. Inequalities in lesbian, gay, bisexual, and transgender (LGBT) health and health care access and utilization in Wisconsin. Prev Med Rep. 2019; 14:100864.
47.
Juarez-CuellarA, ChangY-P. HIV testing in urban transgender individuals: a descriptive study. Transgend Health. 2017; 2:151–155.
48.
KattariSK, WallsNE, SpeerSR, KattariL. Exploring the relationship between transgender-inclusive providers and mental health outcomes among transgender/gender variant people. Soc Work Health Care. 2016; 55:635–650.
49.
KosenkoK, RintamakiL, RaneyS, ManessK. Transgender patient perceptions of stigma in health care contexts. Med Care. 2013; 51:819–822.
50.
LemonsA, BeerL, FinlaysonT, et al.Characteristics of HIV-positive transgender men receiving medical care: United States, 2009–2014. Am J Public Health. 2018; 108:128–130.
51.
MarshallSA, AllisonMK, StewartMK, et al.Highest priority health and health care concerns of transgender and nonbinary individuals in a Southern State. Transgend Health. 2018; 3:190–200.
52.
McDowellM, PardeeDJ, PeitzmeierS, et al.Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health. 2017; 4:252–259.
53.
MelendezRM, ExnerTA, EhrhardtAA, et al.Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health. 2006; 96:1034–1037.
54.
MizunoY, BeerL, HuangP, FrazierEL. Factors associated with antiretroviral therapy adherence among transgender women receiving HIV medical care in the United States. LGBT Health. 2017; 4:181–187.
55.
NewfieldE, HartS, DibbleS, KohlerL. Female-to-male transgender quality of life. Qual Life Res. 2006; 15:1447–1457.
56.
PeitzmeierSM, ReisnerSL, HarigopalP, PotterJ. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender femalesimplications for cervical cancer screening. J Gen Intern Med. 2014; 29:778–784.
57.
PeitzmeierSM, AgénorM, BernsteinIM, et al.“It Can Promote an Existential Crisis”: factors influencing Pap test acceptability and utilization among transmasculine individuals. Qual Health Res. 2017; 27:2138–2149.
58.
Perez-BrumerA, NunnA, HsiangE, et al.“We don't treat your kind”: assessing HIV health needs holistically among transgender people in Jackson, Mississippi. PLoS One. 2018; 13:e0202389.
59.
RachlinK, GreenJ, LombardiE. Utilization of health care among female-to-male transgender individuals in the United States. J Homosex. 2008; 54:243–258.
60.
RadixAE, Lelutiu-WeinbergerC, GamarelKE. Satisfaction and healthcare utilization of transgender and gender non-conforming individuals in NYC: a community-based participatory study. LGBT Health. 2014; 1:302–308.
61.
RahmanM, LiDH, MoskowitzDA. Comparing the healthcare utilization and engagement in a sample of transgender and cisgender bisexual+ persons. Arch Sex Behav. 2019; 48:255–260.
62.
RebackCJ, ClarkK, HollowayIW, FletcherJB. Health disparities, risk behaviors and healthcare utilization among transgender women in Los Angeles County: a comparison from 1998–1999 to 2015–2016. AIDS Behav. 2018; 22:2524–2533.
63.
ReisnerSL, DeutschMB, PeitzmeierSM, et al.Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018; 13:e0190172.
64.
ReisnerSL, PerkovichB, MimiagaMJ. A mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men. AIDS Patient Care STDS. 2010; 24:501–513.
65.
ReisnerSL, WhiteJM, MayerKH, MimiagaMJ. Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center. AIDS Care. 2014; 26:857–864.
66.
ReisnerSL, GamarelKE, DunhamE, et al.Female-to-male transmasculine adult health: a mixed-methods community-based needs assessment. J Am Psychiatr Nurses Assoc. 2013; 19:293–303.
67.
ReisnerSL, HughtoJMW, DunhamEE, et al.Legal protections in public accommodations settings: a critical public health issue for transgender and gender-nonconforming people. Milbank Q. 2015; 93:484–515.
68.
SalazarLF, CrosbyRA, JonesJ, et al.Contextual, experiential, and behavioral risk factors associated with HIV status: a descriptive analysis of transgender women residing in Atlanta, Georgia. Int J STD AIDS. 2017; 28:1059–1066.
69.
SanchezNF, SanchezJP, DanoffA. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009; 99:713–719.
70.
SineathRC, WoodyattC, SanchezT, et al.Determinants of and barriers to hormonal and surgical treatment receipt among transgender people. Transgend Health. 2016; 1:129–136.
71.
StantonMC, AliS, ChaudhuriS. Individual, social and community-level predictors of wellbeing in a US sample of transgender and gender non-conforming individuals. Cult Health Sex. 2017; 19:32–49.
72.
ThompsonHM.Patient perspectives on gender identity data collection in electronic health records: an analysis of disclosure, privacy, and access to care. Transgend Health. 2016; 1:205–215.
73.
TranBNN, EpsteinS, SinghalD, et al.Gender affirmation surgery: a synopsis using American college of surgeons national surgery quality improvement program and national inpatient sample databases. Ann Plast Surg. 2018; 80(Suppl 4):S229–S235.
74.
White-HughtoJM, RoseAJ, PachankisJE, ReisnerSL. Barriers to gender transition-related healthcare: identifying underserved transgender adults in Massachusetts. Transgend Health. 2017; 2:107–118.
75.
WhiteheadJ, ShaverJ, StephensonR. Outness, stigma, and primary health care utilization among rural LGBT populations. PLoS One. 2016; 11:e0146139.
76.
WilsonEC, TurnerC, ArayasirikulS, et al.Housing and income effects on HIV-related health outcomes in the San Francisco Bay Area—findings from the SPNS transwomen of color initiative. AIDS Care. 2018; 30:1356–1359.
77.
WilsonEC, ChenY-H, ArayasirikulS, et al.Connecting the dots: examining transgender women's utilization of transition-related medical care and associations with mental health, substance use, and HIV. J Urban Health Bull N Y Acad Med. 2015; 92:182–192.
78.
YamanisT, MalikM, Del Rio-GonzalezAM, et al.Legal immigration status is associated with depressive symptoms among Latina transgender women in Washington, DC. Int J Environ Res Public Health. 2018; 15:1246.
79.
YangM-F, ManningD, van den BergJJ, OperarioD. Stigmatization and mental health in a diverse sample of transgender women. LGBT Health. 2015; 2:306–312.
80.
BerchickER, HoodE, BarnettJC. Health Insurance Coverage in the United States: 2017. United States Census Bureau. 2018. Available at https://www.census.gov/library/publications/2018/demo/p60-264.html Accessed October6, 2020.
81.
KannanVD, VeaziePJ. Predictors of avoiding medical care and reasons for avoidance behavior. Med Care. 2014; 52:336–345.
82.
ByrneSK.Healthcare avoidance: a critical review. Holist Nurs Pract. 2008; 22:280–292.
83.
KaleEE, DonaldCA, SattlerAR, et al.Opportunities and gaps in primary care preventative health services for transgender patients: a systematic review. Transgend Health. 2016; 1:216–230.
84.
PattersonJG, JabsonJM, BowenDJ. Measuring sexual and gender minority populations in health surveillance. LGBT Health. 2017; 4:82–105.
85.
FlentjeA, BaccaCL, CochranBN. Missing data in substance abuse research? Researchers' reporting practices of sexual orientation and gender identity. Drug Alcohol Depend. 2015; 147:280–284.
86.
WoodW, EaglyAH. Two traditions of research on gender identity. Sex Roles. 2015; 73:461–473.
87.
Department of Health and Human Services. Nondiscrimination in Health Programs and Activities; Final Rule. Natl Arch Rec Adm. 2016; 81:1–99.
88.
Transgender Law Center. Affordable Care Act Fact Sheet. 2016. Available at https://transgenderlawcenter.org/resources/health/aca-fact-sheet Accessed April20, 2020.
89.
JaffeS.Dismantling the ACA without help from Congress. Lancet. 2017; 390:441–442.
90.
Department of Health and HumanServices, Office of theSecretary. Protecting Statutory Conscience Rights in Health Care; Delegations of Authority. Final Rule. 2019. Available at https://www.hhs.gov/sites/default/files/final-conscience-rule.pdf Accessed April8, 2020.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
